About this trial
The goal of this observational study is to determine whether a clinically relevant dose of activated charcoal raises the serum osmolality and osmolal gap in a population of healthy volunteers. Secondarily to determine whether the same dose creates a false positive result using an enzymatic assay.
1. Does a clinically relevant dose of commercially available activated charcoal raise the osmolal gap above the baseline of a healthy volunteer? 2. Does the same dose of charcoal cause a false positive enzymatic assay for ethylene glycol?
Participants will be asked to consume a dose of activated charcoal and have serial blood draws for laboratory measurements.
Eligibility criteria
Qualifiers
Healthy adults
Disqualifiers
Any medical comorbidities
Recent illness
Pregnancy
Prisoners
Trial design
Treatments tested in this trial
- Activated Charcoal
Treatment groups
Locations
1Sponsors and collaborators
State University of New York - Upstate Medical University
Lead sponsor